美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=REMODULIN"
符合检索条件的记录共 12 条
共 1 页，当前第 1 页
返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
REMODULIN 021272 001 NDA TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 1MG/ML Yes Yes 2002/05/21 2002/05/21 UNITED THERAP Prescription
REMODULIN 021272 002 NDA TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 2.5MG/ML Yes Yes 2002/05/21 2002/05/21 UNITED THERAP Prescription
REMODULIN 021272 003 NDA TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 5MG/ML Yes Yes 2002/05/21 2002/05/21 UNITED THERAP Prescription
REMODULIN 021272 004 NDA TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 10MG/ML Yes Yes 2002/05/21 2002/05/21 UNITED THERAP Prescription
REMODULIN 021272 005 NDA TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 20MG/ML Yes Yes 2002/05/21 2021/07/30 UNITED THERAP Prescription
REMODULIN 021272 006 NDA TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 0.1MG/ML Yes Yes 2002/05/21 2023/09/28 UNITED THERAP Prescription
REMODULIN 021272 007 NDA TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 0.2MG/ML Yes Yes 2002/05/21 2023/09/28 UNITED THERAP Prescription
REMODULIN 021272 008 NDA TREPROSTINIL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 0.4MG/ML Yes Yes 2002/05/21 2023/09/28 UNITED THERAP Prescription
REMODULIN 208276 001 NDA TREPROSTINIL SOLUTION;INTRAVENOUS, SUBCUTANEOUS 20MG/20ML (1MG/ML) No No 2018/07/30 2018/07/30 UNITED THERAP Discontinued
REMODULIN 208276 002 NDA TREPROSTINIL SOLUTION;INTRAVENOUS, SUBCUTANEOUS 50MG/20ML (2.5MG/ML) No No 2018/07/30 2018/07/30 UNITED THERAP Discontinued
REMODULIN 208276 003 NDA TREPROSTINIL SOLUTION;INTRAVENOUS, SUBCUTANEOUS 100MG/20ML (5MG/ML) No No 2018/07/30 2018/07/30 UNITED THERAP Discontinued
REMODULIN 208276 004 NDA TREPROSTINIL SOLUTION;INTRAVENOUS, SUBCUTANEOUS 200MG/20ML (10MG/ML) No No 2018/07/30 2018/07/30 UNITED THERAP Discontinued
药品名称，活性成分，申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database